Boosting Cancer Immunotherapy with Anti-CD137 Antibody Therapy.

Yonezawa, Atsushi; Dutt, Suparna; Chester, Cariad; Kim, Jeewon; Kohrt, Holbrook E

Yonezawa, Atsushi; Dutt, Suparna; Chester, Cariad; Kim, Jeewon; Kohrt, Holbrook E.

Afiliação

Yonezawa A; Division of Oncology, Department of Medicine, Stanford University, Stanford, California. Department of Clinical Pharmacology and Therapeutics, Kyoto University Hospital, Sakyo-ku, Kyoto, Japan.
Dutt S; Immunology and Rheumatology, Stanford University, Stanford, California.
Chester C; Division of Oncology, Department of Medicine, Stanford University, Stanford, California. Institute for Immunity, Transplantation and Infection, Stanford University, Stanford, California.
Kim J; Transgenic, Knockout and Tumor Model Center, Stanford Cancer Institute, School of Medicine, Stanford University, Stanford, California.
Kohrt HE; Division of Oncology, Department of Medicine, Stanford University, Stanford, California. kohrt@stanford.edu.

Clin Cancer Res ; 21(14): 3113-20, 2015 Jul 15.

Article em En | MEDLINE | ID: mdl-25908780

Assuntos

Anticorpos Monoclonais/imunologia; Imunoterapia/métodos; Neoplasias/terapia; Membro 9 da Superfamília de Receptores de Fatores de Necrose Tumoral/imunologia; Animais; Anticorpos Monoclonais/farmacologia; Humanos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Membro 9 da Superfamília de Receptores de Fatores de Necrose Tumoral / Imunoterapia / Anticorpos Monoclonais / Neoplasias Limite: Animals / Humans Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google